164 related articles for article (PubMed ID: 19921476)
1. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
Chen T; Zhu J
Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
[TBL] [Abstract][Full Text] [Related]
3. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
5. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
Zhang C; Tu Z; Du S; Wang Y; Wang Q
Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
[TBL] [Abstract][Full Text] [Related]
7. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma.
Chu T; Chen X; Yu J; Xiao J; Fu Z
Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785
[TBL] [Abstract][Full Text] [Related]
10. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Huang T; Chen MH; Wu MY; Wu XY
Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD
Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
[TBL] [Abstract][Full Text] [Related]
15. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the Wnt/β-catenin signaling pathway and the EMMPRIN/MMP-2, 9 route in periodontitis.
Liu X; Zhang Z; Pan S; Shang S; Li C
J Periodontal Res; 2018 Oct; 53(5):842-852. PubMed ID: 29900539
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L
Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934
[TBL] [Abstract][Full Text] [Related]
19. CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts.
Aoki M; Koga K; Miyazaki M; Hamasaki M; Koshikawa N; Oyama M; Kozuka-Hata H; Seiki M; Toole BP; Nabeshima K
BMC Cancer; 2019 Sep; 19(1):912. PubMed ID: 31510956
[TBL] [Abstract][Full Text] [Related]
20. High Expression of Matrix Metalloproteinase-11 indicates Poor Prognosis in Human Cholangiocarcinoma.
Tongtawee T; Kaewpitoon SJ; Loyd R; Chanvitan S; Leelawat K; Praditpol N; Jujinda S; Kaewpitoon N
Asian Pac J Cancer Prev; 2015; 16(9):3697-701. PubMed ID: 25987024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
